AAAAAA
Results: 1-25/129
Authors:
MORONI M
BRIGIDA C
POLI S
VALLE M
Citation: M. Moroni et al., Fixing chromium and lead in ceramic materials: a petrological approach to inertization and recycling of toxic industrial waste, Periodico di mineralogia (Testo stampato) , 73(3), 2004, pp. 99-111
Authors:
TEIXEIRA C
FERRARIO A
GIRARDI V A V
GRIECO G
MORONI M
Citation: C. Teixeira et al., Preliminary Re-Os isotopic data in the PGE rich chromitites of the Luanga ultramafic complex (Carajas, Parà State; Brazil), Ofioliti (Bologna) Bollettino del gruppo di lavoro sulle ofioliti mediterranee , 24(1A), 1999, pp. 176-177
Authors:
HILBERER A
MORONI M
GILL RE
BROUWER HJ
KRASNIKOV VV
PHAM TA
MALLIARAS GG
VEENSTRA S
WERTS MPL
VANHUTTEN PF
HADZIIOANNOU G
Citation: A. Hilberer et al., PHOTONIC MATERIALS FOR ELECTROLUMINESCENT, LASER AND PHOTOVOLTAIC DEVICES, Macromolecular symposia, 125, 1998, pp. 99-109
Authors:
PORTA C
MAZZUCCHELLI I
FERRARI S
MORONI M
FOSSATI GL
RICCI G
DANOVA M
BRUGNATELLI S
RICCARDI A
Citation: C. Porta et al., CD11B EXPRESSION ON LYMPHOCYTES (LY) OF RENAL-CELL CARCINOMA (RCC) PATIENTS AFTER A SINGLE COURSE OF VERY LOW-DOSE SC IL-2, Annals of oncology, 9, 1998, pp. 294-294
Authors:
MORONI M
PORTA C
TUA A
MAGNONE S
GRIGNANI G
Citation: M. Moroni et al., PLATELET AGONISTS INDUCE CA2(-CELLS BY OPENING DISTINCT RECEPTOR-OPERATED CHANNELS - AN EFFECT UNRELATED TO THE PRESENCE OF CLASSICAL MULTIDRUG-RESISTANCE PHENOTYPE() TRANSIENTS IN TUMOR), The Cancer journal, 11(3), 1998, pp. 141-146
Authors:
MORONI M
BALOTTA C
RUSCONI S
Citation: M. Moroni et al., OVERVIEW ON HIV-1-RELATED DRUG-RESISTANCE - FROM THEORY TO CLINICAL-PRACTICE, Journal of biological regulators and homeostatic agents, 12(1-2), 1998, pp. 15-18
Authors:
TORTOLI E
BRUNELLO F
CAGNI AE
COLOMBRITA D
DIONISIO D
GRISENDI L
MANFRIN V
MORONI M
TOSI CP
PINSI G
SCARPARO C
SIMONETTI MT
Citation: E. Tortoli et al., MYCOBACTERIUM GENAVENSE IN AIDS PATIENTS, REPORT OF 24 CASES IN ITALYAND REVIEW OF THE LITERATURE, European journal of epidemiology, 14(3), 1998, pp. 219-224
Authors:
PORTA C
MORONI M
GRIGNANI G
Citation: C. Porta et al., PLATELET AGONISTS AND CALCIUM HOMEOSTASIS IN ENDOTHELIAL-CELLS - POSSIBLE ROLE IN THE INTERACTION OF ENDOTHELIUM WITH HEMOSTATIC SYSTEM, Haematologica, 83(7), 1998, pp. 610-615
Authors:
PARRAVICINI C
BESTETTI G
LAURI E
CAPRA M
RIDOLFO A
SANTAMBROGIO S
BERTI E
ROSSI E
PIZZUTO M
MORONI M
CORBELLINO M
GALLI M
Citation: C. Parravicini et al., SEROEPIDEMIOLOGY OF KAPOSIS-SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) INFECTION IN MILAN, ITALY, Haematologica, 83(5), 1998, pp. 469-469
Authors:
AMADEO A
BERTULEZZI G
CIVELLI L
PORTA C
MORONI M
Citation: A. Amadeo et al., PLASMA AND URINARY ENDOTHELIN-1 TITERS AND PLASMA VON-WILLEBRAND ACTIVITY IN PSEUDOXANTHOMA-ELASTICUM, Haematologica, 83(10), 1998, pp. 952-953
Authors:
MORONI M
PORTA C
Citation: M. Moroni et C. Porta, POSSIBLE EFFICACY OF ALLOPURINOL VAGINAL WASHINGS IN THE TREATMENT OFCHEMOTHERAPY-INDUCED VAGINITIS, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 171-172
Authors:
MONFORTE AD
TESTA L
GIANOTTO M
GORI A
FRANZETTI F
SOLLIMA S
BINI T
MORONI M
Citation: Ad. Monforte et al., INDINAVIR-RELATED ALOPECIA, AIDS, 12(3), 1998, pp. 328-328
Authors:
MONFORTE AD
TESTA L
ADORNI F
CHIESA E
BINI T
MOSCATELLI GC
ABELI C
RUSCONI S
SOLLIMA S
BALOTTA C
MUSICCO M
GALLI M
MORONI M
Citation: Ad. Monforte et al., CLINICAL OUTCOME AND PREDICTIVE FACTORS OF FAILURE OF HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY IN ANTIRETROVIRAL-EXPERIENCED PATIENTS IN ADVANCED STAGES OF HIV-1 INFECTION, AIDS, 12(13), 1998, pp. 1631-1637
Authors:
GERNA G
MONFORTE AD
ZAVATTONI M
SARASINI A
TESTA L
REVELLO MG
MORONI M
Citation: G. Gerna et al., SHARP DROP IN THE PREVALENCE OF HUMAN CYTOMEGALOVIRUS LEUKO-DNAEMIA IN HIV-INFECTED PATIENTS FOLLOWING HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY, AIDS, 12(1), 1998, pp. 118-120
Authors:
ALESSIANI M
VAI L
JEMOS V
DIONIGI P
SPADA M
PORTA C
MORONI M
NASTASI G
FOSSATI GS
ZONTA A
Citation: M. Alessiani et al., CATHETER SEEDING OF HEPATOCELLULAR-CARCINOMA FOLLOWING PLACEMENT OF ATOTAL IMPLANTABLE ACCESS PORT SYSTEM, Hepato-gastroenterology, 45(19), 1998, pp. 206-208
Authors:
DALPOZZO A
MUZI L
MORONI M
RONDANIN R
DECASTIGLIONE R
BRAVO P
ZANDA M
Citation: A. Dalpozzo et al., SYNTHESIS OF RGD ANALOGS CONTAINING ALPHA-TFM-ARGININE AS POTENTIAL FIBRINOGEN RECEPTOR ANTAGONISTS, Tetrahedron, 54(22), 1998, pp. 6019-6028
Authors:
PORTA C
MORONI M
FERRARI S
NASTASI G
Citation: C. Porta et al., ENDOTHELIN-1 AND 5-FLUOROURACIL-INDUCED CARDIOTOXICITY, Neoplasma, 45(2), 1998, pp. 81-82
Authors:
DIANI G
POMA G
NOVAZZI F
ZANIRATO S
PORTA C
MORONI M
DERIL GVM
MORATTI R
Citation: G. Diani et al., INCREASED SERUM LIPASE WITH ASSOCIATED NORMOAMYLASEMIA IN CANCER-PATIENTS, Clinical chemistry, 44(5), 1998, pp. 1043-1045
EOSINOPHILS AND SERUM EOSINOPHILIC CATIONIC PROTEINS IN INTERLEUKIN-2-BASED IMMUNOTHERAPY FOR CANCER
Authors:
PORTA C
MORONI M
DEAMICI M
Citation: C. Porta et al., EOSINOPHILS AND SERUM EOSINOPHILIC CATIONIC PROTEINS IN INTERLEUKIN-2-BASED IMMUNOTHERAPY FOR CANCER, British Journal of Haematology, 100(3), 1998, pp. 607-608
Authors:
CECCONI I
MORONI M
VILARDO PG
DALMONTE M
BORELLA P
RASTELLI G
COSTANTINO L
GARLAND D
CARPER D
PETRASH JM
DELCORSO A
MURA U
Citation: I. Cecconi et al., OXIDATIVE MODIFICATION OF ALDOSE REDUCTASE INDUCED BY COPPER-ION - FACTORS AND CONDITIONS AFFECTING THE PROCESS, Biochemistry (Easton), 37(40), 1998, pp. 14167-14174
Authors:
PORTA C
MORONI M
BOBBIOPALLAVICINI E
TINELLI C
REGAZZIBONORA M
Citation: C. Porta et al., NITRATE PLASMA-LEVEL AS A MARKER OF NITRIC-OXIDE PRODUCTION AFTER SUBCUTANEOUS INTERLEUKIN-2 IMMUNOTHERAPY, Journal of the National Cancer Institute, 89(20), 1997, pp. 1545-1545
Authors:
CECCAGNOLI D
MINELLI A
MORONI M
TATICCHI MI
Citation: D. Ceccagnoli et al., MONTHLY VARIATIONS OF 5'NUCLEOTIDASE IN LOPHOPUS-CRYSTALLINUS, A FRESH-WATER BRYOZOAN, Italian journal of zoology, 64(2), 1997, pp. 131-134
Authors:
MINELLI A
MORONI M
MEZZASOMA I
Citation: A. Minelli et al., HUMAN SEMINAL PLASMA SOLUBLE 5'-NUCLEOTIDASE - REGULATORY ASPECTS OF THE DEPHOSPHORYLATION OF NUCLEOSIDE 5'-MONOPHOSPHATES, Biochemical and molecular medicine, 61(1), 1997, pp. 95-101
Authors:
MORONI M
PORTA C
FINOTTI N
REGAZZIBONORA M
BERTORELLI L
BORASIO E
GRECO R
MARZATICO F
Citation: M. Moroni et al., AMIFOSTINE (WR-2721, ETHYOL(TM)) CAN PROTECT HUMAN ENDOTHELIAL BUT NOT TUMOR-CELLS FROM CISPLATIN-INDUCED CYTOTOXICITY - AN IN-VITRO STUDY, Oncology Reports, 4(4), 1997, pp. 729-732
Authors:
NASTASI G
PORTA C
MORONI M
ALESSIANI M
FOSSATI G
Citation: G. Nastasi et al., INTRAHEPATIC FLUORODEOXYURIDINE TO TREAT UNRESECTABLE HEPATOCELLULAR-CARCINOMA PATIENTS, Oncology Reports, 4(3), 1997, pp. 511-514